Screener
Recursion Pharmaceuticals, Inc. RXRX EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (134,968) | (176,227) | (263,472) | (367,595) |
| Other income (loss), net | 3,962 | 4,330 | 10,359 | (6,947) |
| Loss before income tax benefit | (131,006) | (171,897) | (253,113) | (374,542) |
| Income tax benefit | 1 | — | 4,604 | 158 |
| Net loss | $(131,005) | $(171,897) | $(248,509) | $(374,384) |
| Per share data | ||||
| Net loss per share of Class A, B and Exchangeable common stock, basic and diluted | $(0.25) | $(0.41) | $(0.47) | $(0.91) |
| Weighted-average shares (Class A, B and Exchangeable) outstanding, basic and diluted | 532,460,085 | 417,361,147 | 530,890,753 | 410,268,199 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s EPS (basic)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported EPS (basic) of -$0.25 in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s EPS (basic) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s EPS (basic) increased by 39.0% year-over-year, from -$0.41 to -$0.25.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s EPS (basic)?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s EPS (basic) has grown at a -11.1% compound annual growth rate (CAGR), from -$2.31 to -$1.44.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Recursion Pharmaceuticals, Inc.'s eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude